{"layout":"indicator","sdg_goal":"3","goal_number":"3","indicator_number":"3.b.1","indicator_sort_order":"03-bb-01","permalink":"/3-b-1/","reporting_status":"complete","published":true,"data_non_statistical":false,"national_indicators_available":"<ul style='padding-left: 25px;'><li>DTP-Impfquote zum Schuleintritt</li> <li> HPV-Impfquoten bei 15-j\u00e4hrigen M\u00e4dchen und Jungen</li> <li> Masern-Impfquote zum Schuleintritt</li> <li> Pneumokokken-Impfquote zum Schuleintritt</li></ul>","comparison_sdg":"Die Zeitreihen entsprechen den UN-Metadaten.","goal_meta_national_link":"https://sdg-indikatoren.de/public/Meta/3.b.1.pdf","goal_meta_national_link_text":"Metadaten zu den dargestellten Zeitreihen","indicator_name":"Anteil der Zielbev\u00f6lkerung, der alle im jeweiligen nationalen Programm vorgesehenen Impfungen erhalten hat","target_name":"Forschung und Entwicklung zu Impfstoffen und Medikamenten f\u00fcr \u00fcbertragbare und nicht\u00fcbertragbare Krankheiten, von denen haupts\u00e4chlich Entwicklungsl\u00e4nder betroffen sind, unterst\u00fctzen, den Zugang zu bezahlbaren unentbehrlichen Arzneimitteln und Impfstoffen gew\u00e4hrleisten, im Einklang mit der Erkl\u00e4rung von Doha \u00fcber das TRIPS-\u00dcbereinkommen und die \u00f6ffentliche Gesundheit, die das Recht der Entwicklungsl\u00e4nder bekr\u00e4ftigt, die Bestimmungen in dem \u00dcbereinkommen \u00fcber handelsbezogene Aspekte der Rechte des geistigen Eigentums \u00fcber Flexibilit\u00e4ten zum Schutz der \u00f6ffentlichen Gesundheit voll auszusch\u00f6pfen, und insbesondere den Zugang zu Medikamenten f\u00fcr alle zu gew\u00e4hrleisten","target_id":"3.b","un_designated_tier_url":"https://unstats.un.org/sdgs/iaeg-sdgs/tier-classification/'","un_designated_tier_url_text":"Tier I</a>","un_designated_tier_url_alert":"der Statistischen Division der Vereinten Nationen","un_custodian_agency":"Weltgesundheitsorganisation (WHO)<br>Kinderhilfswerk der Vereinten Nationen (UNICEF)","goal_meta_link":"https://unstats.un.org/sdgs/metadata/files/Metadata-03-0b-01.pdf","goal_meta_link_text":"Metadaten zu diesem Indikator","goal_meta_link_alert":"der Statistischen Division der Vereinten Nationen","source_active_1":true,"source_organisation_1":"<a href=\"https://www.destatis.de\" target=\"_blank\"> Statistisches Bundesamt (Destatis) </a>","source_organisation_logo_1":"<a href=\"https://www.destatis.de\" target=\"_blank\"><img src=\"https://sdg-indikatoren.de/public/OrgImgDe/destatis.png\" alt=\"Logo destatis\" style=\"height:60px; width:148px\"/></a>","source_url_1":"http://www.gbe-bund.de/gbe10/I?I=831:27110398","source_url_text_1":"Impfquote der Kinder mit vorgelegtem Impfausweis bei Einschulungsuntersuchungen \u2013 GBE","source_active_2":true,"source_organisation_2":"<a href=\"https://www.rki.de/DE/Home/homepage_node.html\" target=\"_blank\" onclick=\"return confirm_alert('des Robert Koch-Instituts','De');\"> Robert Koch-Institut (RKI) </a>","source_organisation_logo_2":"<a href=\"https://www.rki.de/DE/Home/homepage_node.html\" target=\"_blank\" onclick=\"return confirm_alert('des Robert Koch-Instituts','De');\"><img src=\"https://sdg-indikatoren.de/public/OrgImgDe/rki.png\" alt=\"Logo rki\" style=\"height:60px; width:148px\"/></a>","source_url_2":"https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2022/Ausgaben/48_22.pdf","source_url_text_2":"Epidemiologisches Bulletin  48/2022","source_url_alert_2":"des Robert Koch-Instituts","source_active_3":false,"source_active_4":false,"source_active_5":false,"source_active_6":false,"data_show_map":false,"data_start_values":[{"field":"timeseries","value":"dtp vaccination coverage at school entry"},{"field":"timeseries","value":"hpv vaccination coverages among 15 years old girls and boys"},{"field":"timeseries","value":"measles vaccination coverage at school entry"},{"field":"timeseries","value":"pneumococcal vaccination coverage at school entry"}],"computation_units":"Prozent","copyright":"&copy; Statistisches Bundesamt (Destatis), 2024","data_footnotes":"DTP: Diphtherie, Tetanus, Pertussis (Keuchhusten).<br>\u2022 HPV: Humane Papillomviren.<br>\u2022 HPV-Impfquote bei 15-j\u00e4hrigen M\u00e4dchen und Jungen: Daten f\u00fcr M\u00e4dchen sind erst ab 2011 und Daten f\u00fcr Jungen erst ab 2019 verf\u00fcgbar. Grund: Einf\u00fchrung der HPV-Impfung zus\u00e4tzlich f\u00fcr Jungen im Juni 2018.<br>\u2022 Impfquoten zum Schuleintritt: Keine Daten f\u00fcr 2021 und 2022, da pandemiebedingt keine fl\u00e4chendeckende Erfassung.","graph_title":"Zielbev\u00f6lkerung, die alle im nationalen Programm vorgesehenen Impfungen erhalten hat","graph_subtitle":null,"graph_type":"line","graph_stepsize":[{"step":10.0}],"show_line":true,"span_gaps":true,"precision":[{"decimals":1}],"previous":"3-a-1","next":"3-b-2","national_geographical_coverage":"Deutschland","page_content":"\n<span></span>","en":{"language":"en","national_indicators_available":"<ul style='padding-left: 25px;'><li>DTP vaccination coverage at school entry</li> <li> HPV vaccination coverages among 15 years old girls and boys</li> <li> Measles vaccination coverage at school entry</li> <li> Pneumococcal vaccination coverage at school entry</li></ul>","comparison_sdg":"The time series are compliant with the UN metadata.","goal_meta_national_link_text":"Metadata on the presented time series","indicator_name":"Proportion of the target population covered by all vaccines included in their national programme","target_name":"Support the research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration on the TRIPS Agreement and Public Health, which affirms the right of developing countries to use to the full the provisions in the Agreement on Trade-Related Aspects of Intellectual Property Rights regarding flexibilities to protect public health, and, in particular, provide access to medicines for all","un_designated_tier_url":"https://unstats.un.org/sdgs/iaeg-sdgs/tier-classification/","un_designated_tier_url_text":"Tier I","un_desgnated_tier_alert":"the United Nations Statistics Division","un_custodian_agency":"World Health Organization (WHO)<br>United Nations International Children's Fund (UNICEF)","goal_meta_link_text":"Metadata on this indicator","goal_meta_link_alert":"the Statistical Devision of the UN","goal_meta_2_link_text":null,"goal_meta_3_link_text":null,"source_organisation_1":"<a href=\"https://www.destatis.de/EN\" target=\"_blank\"> Federal Statistical Office (Destatis) </a>","source_organisation_logo_1":"<a href=\"https://www.destatis.de/EN\" target=\"_blank\"><img src=\"https://sdg-indikatoren.de/public/OrgImgEn/destatis.png\" alt=\"Logo destatis\" style=\"height:60px; width:148px\"/></a>","source_url_1":"http://www.gbe-bund.de/gbe10/I?I=831:27110398E","source_url_text_1":"Vaccination coverage of children presenting their vaccination card at school entry health examinations \u2013 GBE","source_organisation_2":"<a href=\"https://www.rki.de/EN/Home/homepage_node.html\" target=\"_blank\" onclick=\"return confirm_alert('the Robert Koch Institute','En');\"> Robert Koch Institute </a>","source_organisation_logo_2":"<a href=\"https://www.rki.de/EN/Home/homepage_node.html\" target=\"_blank\" onclick=\"return confirm_alert('the Robert Koch Institute','En');\"><img src=\"https://sdg-indikatoren.de/public/OrgImgEn/rki.png\" alt=\"Logo rki\" style=\"height:60px; width:148px\"/></a>","source_url_2":"https://www.rki.de/DE/Content/Infekt/EpidBull/Archiv/2022/Ausgaben/48_22.pdf","source_url_text_2":"Epidemiological Bulletin 48/2022 (only available in German)","source_url_alert_2":"the Robert Koch Institute","computation_units":"Percentage","copyright":"&copy; Federal Statistical Office (Destatis), 2024","data_footnotes":"DTP: Diphtheria, tetanus, pertussis, <br>\u2022 HPV: Humane papillomavirus.<br>\u2022 HPV vaccination coverage among 15 year-old girls and boys: Data for girls is only available from 2011 and data for boys from 2019. Reason: Introduction of HPV vaccination additionally for boys in June 2018.<br>\u2022 Vaccination coverage at school entry: No data for 2021 and 2022, as no comprehensive coverage due to pandemic.","graph_title":"Target population covered by all vaccines included in their national programme","graph_subtitle":null,"national_geographical_coverage":"Germany","page_content":"\n<span></span>"},"national_metadata_updated_date":"2024-05-31","national_data_updated_date":"2023-01-30","target_number":"3.b"}